Gene Polymorphisms of m6A Erasers FTO and ALKBH1 Associated with Susceptibility to Gastric Cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020. doi:10.3322/caac.21590
   Web of Science ®Google Scholar
• Libânio D, Rodrigues JR, Bento MJ, et al. Gastric cancer incidence and mortality trends 2007–2016 in three European countries. Endoscopy. 2021. doi:10.1055/a-1673-1118
   Web of Science ®Google Scholar
• Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review. Gastroenterology. 2021;161(4):1325–1332.e7. doi:10.1053/j.gastro.2021.06.078
   PubMed Web of Science ®Google Scholar
• Waddingham W, Nieuwenburg SAV, Carlson S, et al. Recent advances in the detection and management of early gastric cancer and its precursors. Frontline Gastroenterol. 2021;12(4):322–331. doi:10.1136/flgastro-2018-101089
   PubMed Web of Science ®Google Scholar
• Lam SY, Mommersteeg MC, Yu B, et al. Toll-like receptor 1 locus re-examined in a genome-wide association study update on anti-Helicobacter pylori IgG titers. Gastroenterology. 2022;162:1705–1715. doi:10.1053/j.gastro.2022.01.011
   PubMed Web of Science ®Google Scholar
• Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012. doi:10.3390/ijms21114012
   PubMed Web of Science ®Google Scholar
• Batista PJ, Molinie B, Wang J, et al. m6A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2015;15(6):707–719. DOI:10.1016/j.stem.2014.09.019.m
   Web of Science ®Google Scholar
• Dai D, Wang H, Zhu L, Jin H, Wang X. N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis. 2018;9(2):124. doi:10.1038/s41419-017-0129-x
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng D, Wang F, Xu Y, Yu H, Zhang H. Expression of demethylase genes, FTO and ALKBH1, is associated with prognosis of gastric cancer. Dig Dis Sci. 2019;64(6):1503–1513. doi:10.1007/s10620-018-5452-2
   PubMed Web of Science ®Google Scholar
• Alemu E, He C, Klungland A. ALKBHs-facilitated RNA modifications and de-modifications. DNA Repair. 2016;44(0027):87–91. doi:10.1016/j.dnarep.2016.05.026
   PubMed Web of Science ®Google Scholar
• Wu G, Yan Y, Cai Y, et al. ALKBH1-8 and FTO: potential therapeutic targets and prognostic biomarkers in lung adenocarcinoma pathogenesis. Front Cell Dev Biol. 2021;9:1–12. doi:10.3389/fcell.2021.633927
   Web of Science ®Google Scholar
• Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39(6):724–726. doi:10.1038/ng2048
   PubMed Web of Science ®Google Scholar
• Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889–894. doi:10.1126/science.1141634
   PubMed Web of Science ®Google Scholar
• Haupt A, Thamer C, Machann J, et al. Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity. 2008;16(8):1969–1972. doi:10.1038/oby.2008.283
   PubMed Web of Science ®Google Scholar
• Cauchi S, Stutzmann F, Cavalcanti-Proença C, et al. Combined effects of MC4R and FTO common genetic variants on obesity in European general populations. J Mol Med. 2009;87(5):537–546. doi:10.1007/s00109-009-0451-6
   PubMed Web of Science ®Google Scholar
• Wen W, Cho Y-S, Zheng W, et al. Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet. 2012;44(3):307–311. doi:10.1038/ng.1087
   PubMed Web of Science ®Google Scholar
• Jiang Y, Mei H, Lin Q, et al. Interaction effects of FTO rs9939609 polymorphism and lifestyle factors on obesity indices in early adolescence. Obes Res Clin Pract. 2019;13(4):352–357. doi:10.1016/j.orcp.2019.06.004
   PubMed Web of Science ®Google Scholar
• da Fonseca ACP, Abreu GM, Zembrzuski VM, et al. The association of the fat mass and obesity-associated gene (FTO) rs9939609 polymorphism and the severe obesity in a Brazilian population. Diabetes Metab Syndr Obes. 2019;12:667–684. doi:10.2147/DMSO.S199542
   PubMed Web of Science ®Google Scholar
• Mehrdad M, Fardaei M, Fararouei M, Eftekhari MH. The association between FTO rs9939609 gene polymorphism and anthropometric indices in adults. J Physiol Anthropol. 2020;39(1):14. doi:10.1186/s40101-020-00224-y
   PubMed Web of Science ®Google Scholar
• Kaklamani V, Yi N, Sadim M, et al. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet. 2011;12:52. doi:10.1186/1471-2350-12-52
   PubMed Web of Science ®Google Scholar
• Hernández-Caballero ME, Sierra-Ramírez JA. Single nucleotide polymorphisms of the FTO gene and cancer risk: an overview. Mol Biol Rep. 2015;42(3):699–704. doi:10.1007/s11033-014-3817-y
   PubMed Web of Science ®Google Scholar
• Hu L, Wu C, Zhao X, et al. Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res. 2012;18(19):5507–5514. doi:10.1158/1078-0432.CCR-12-1202
   PubMed Web of Science ®Google Scholar
• Chen LZ, He CY, Su X, et al. SPP1 rs4754 and its epistatic interactions with SPARC polymorphisms in gastric cancer susceptibility. Gene. 2018;640:43–50. doi:10.1016/j.gene.2017.09.053
   PubMed Web of Science ®Google Scholar
• Li Y, He HC, Zhou DL, et al. Associations between lncRNA-related polymorphisms and hepatocellular carcinoma risk: a two-stage case–control study. J Gastroenterol Hepatol. 2021;36(1):233–239. doi:10.1111/jgh.15118
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2005;24(9):1291–1306. doi:10.1002/sim.2010
   PubMed Web of Science ®Google Scholar
• Wang F, Fu X, Chen P, et al. SPSB1-mediated HnRNP A1 ubiquitylation regulates alternative splicing and cell migration in EGF signaling. Cell Res. 2017;27(4):540–558. doi:10.1038/cr.2017.7
   PubMed Web of Science ®Google Scholar
• Luo A, Yang L, Liu X, Yang X. Genetic variants in METTL14 are associated with the risk of acute lymphoblastic leukemia in Southern Chinese children: a five-center case-control study. Cancer Manag Res. 2021;Volume 13:9189–9200. doi:10.2147/CMAR.S335925
   Web of Science ®Google Scholar
• Li Y, Xue XW, Luo YF, Wu HW, Chen J, Zhou WX. Clinicopathologic features of gastric adenocarcinoma based on the revised Lauren’s classification. Zhonghua bing li xue za zhi. 2018;47(7):486–491. doi:10.3760/cma.j.issn.0529-5807.2018.07.002
   PubMedGoogle Scholar
• Lan N, Lu Y, Zhang Y, et al. FTO – a common genetic basis for obesity and cancer. Front Genet. 2020;11:1–12. doi:10.3389/fgene.2020.559138
   PubMed Web of Science ®Google Scholar
• Guimarães-Teixeira C, Barros-Silva D, Lobo J, et al. Deregulation of N6-methyladenosine RNA modification and its erasers FTO/ALKBH5 among the main renal cell tumor subtypes. J Pers Med. 2021;11(10). doi:10.3390/jpm11100996
   PubMed Web of Science ®Google Scholar
• Xiao Y, Thakkar KN, Zhao H, et al. The m(6)A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor. Proc Natl Acad Sci U S A. 2020;117(35):21441–21449. doi:10.1073/pnas.2000516117
   PubMed Web of Science ®Google Scholar
• Wen L, Pan X, Yu Y, Yang B. Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity. BMC Urol. 2020;20(1):39. doi:10.1186/s12894-020-00612-7
   PubMed Web of Science ®Google Scholar
• Zhao C, Liu Y, Ju S, Wang X. Pan-cancer analysis of the n6-methyladenosine eraser FTO as a potential prognostic and immunological biomarker. Int J Gen Med. 2021;14:7411–7422. doi:10.2147/IJGM.S331752
   PubMed Web of Science ®Google Scholar
• Kodach LL, Peppelenbosch MP. Targeting the myeloid-derived suppressor cell compartment for inducing responsiveness to immune checkpoint blockade is best limited to specific subtypes of gastric cancers. Gastroenterology. 2021;161(2):727. doi:10.1053/j.gastro.2021.03.047
   PubMed Web of Science ®Google Scholar
• Li H, Zhang Y, Guo Y, et al. ALKBH1 promotes lung cancer by regulating m6A RNA demethylation. Biochem Pharmacol. 2021;189:114284. doi:10.1016/j.bcp.2020.114284
   PubMed Web of Science ®Google Scholar
• Iles MM, Law MH, Stacey SN, et al. A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet. 2013;45(4):428–432, 432e1. doi:10.1038/ng.2571
   PubMed Web of Science ®Google Scholar
• Liu J, Wang D, Zhou J, et al. N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization. Arch Toxicol. 2021;95(5):1621–1629. doi:10.1007/s00204-021-03021-3
   PubMed Web of Science ®Google Scholar